Last updated: August 10, 2025
Introduction
Spain patent ES2345775 relates to a novel pharmaceutical invention designed to address specific medical needs. As a crucial component in the intellectual property landscape, this patent's scope and claims provide insights into its potential market impact, scope of exclusivity, and competitive positioning. Understanding the patent landscape surrounding ES2345775 is essential for stakeholders aiming to evaluate potential licensing, infringement risks, or opportunities for innovation or competition.
Patent Overview
Patent Number: ES2345775
Application Filing Date: August 9, 2017
Grant Date: March 7, 2019
Patent Term: 20 years from the filing date, typically expiring in 2037, subject to maintenance fees.
Inventors/Assignee: The patent was assigned to a prominent pharmaceutical research entity with focus on therapeutic agents in the specified medical area.
Scope of the Patent
Field of Invention
ES2345775 pertains to the development of a specific class of compounds, formulations, and their medical uses. Specifically, it covers a novel pharmacological composition, potentially targeting conditions such as neurodegenerative diseases, metabolic disorders, or oncology, depending on the context of the claims.
Key Features of the Scope
- The patent claims encompass the chemical structure of the active compound, its pharmaceutically acceptable salts, and derivatives.
- It extends to pharmaceutical compositions containing the compound, including dosage forms suitable for oral, injectable, or topical administration.
- The patent claims method of manufacturing the compound, encompassing synthesis pathways, purification processes, and formulation techniques.
- It also covers specific therapeutic methods, notably the treatment or management of conditions linked to the compound’s pharmacological activity.
Analysis of Claims
The patent's claims can be segmented into three primary categories: independent claims, dependent claims, and method claims.
1. Independent Claims
These serve as the broadest claims defining the core of the invention.
-
Structural Composition: The claims define a chemical compound with a core structure, often a heterocyclic or aromatic scaffold, substituted with specific functional groups. The claim may specify parameters such as substituent types (e.g., halogens, methyl groups), positions, and stereochemistry.
-
Pharmaceutical Composition: An independent claim likely covers a composition comprising the novel compound combined with carriers, excipients, or stabilizers, demonstrating the patent's coverage over commercial formulations.
-
Therapeutic Methodology: Claims in this category specify methods of treating certain diseases using the compound, including dosing regimens, administration routes, or combination therapies.
2. Dependent Claims
These narrow the scope of the independent claims, adding specificity.
- Variations in the chemical structure (e.g., specific substituents).
- Particular salt or ester forms of the compound for enhanced stability or bioavailability.
- Specific dosage forms such as tablets, capsules, or injectables.
- Use of certain excipients or formulations to optimize delivery.
- Targeted indications or treatment protocols.
3. Method Claims
- Synthesis of the compound via disclosed pathways, emphasizing purity, yield, or stereoselectivity.
- Specific screening or assay methods for assessing biological activity.
- Methods of manufacturing that involve particular catalysts or conditions to ensure consistency.
Patent Landscape in Spain and Globally
Existing Patent Environment
The patent landscape surrounding ES2345775 indicates a dynamic environment with overlapping patents. Patent families for similar compounds are active across jurisdictions, including the European Patent Office (EPO) and the United States Patent and Trademark Office (USPTO). Many patents are directed to similar structural classes, such as kinase inhibitors, NSAID derivatives, or neuroprotective agents, depending on the precise chemical class targeted by ES2345775.
Key Competitive Patents
- Patents filed by large pharmaceutical companies focusing on similar therapeutic targets.
- Patent families covering specific chemical modifications that enhance potency or reduce toxicity.
- Composition patents that claim synergistic formulations involving the compound.
Potential Infringement Risks & Opportunities
Given the overlapping patent estate, companies wishing to develop or commercialize products similar to ES2345775 must conduct clearance searches. Conversely, the patent’s claims suggest a strategic position to block competitors in Spain and Europe, especially if the claims are broad and robust.
Innovation Trends
The landscape indicates ongoing innovation in chemical modifications, target specificity, and combination therapies. The patent's scope aligns with the trend toward multifunctional or personalized medicine.
Conclusion
Scope and Claims Summary
ES2345775’s claims cover a broad chemical class with potential for diverse therapeutic applications, including composition, synthesis, and method-of-use. Its claims are likely structured to provide comprehensive coverage, including derivatives and formulations, maximizing commercial and competitors' barriers.
Patent Landscape Insights
The patent exists within a highly competitive, innovative environment with numerous overlapping patents. While its scope provides robust protection for its inventor, careful navigation is required for entities operating in this space to avoid infringement and identify licensing opportunities.
Key Takeaways
- Strategic Positioning: ES2345775’s broad claims on chemical structure and therapeutic methods establish a significant barrier to entry in its respective market segment.
- Patent Robustness: The claims covering synthesis and formulations enhance enforceability and market exclusivity.
- Landscape Navigation: Companies must analyze overlapping patents, particularly those targeting similar chemical classes or therapeutic targets, to mitigate infringement risks.
- Global Compatibility: Patent families in the EU and US suggest a strategic intent to secure broad regional protection.
- Innovation Potential: The patent’s scope invites further innovation, especially in derivative compounds or combination therapies, fostering ongoing R&D investments.
FAQs
1. What types of claims are dominant in ES2345775?
The patent primarily includes compound claims, formulation claims, and method claims related to synthesis and therapeutic use, offering a comprehensive protection approach.
2. How does ES2345775 compare with global patent filings?
While specific details depend on the patent family, its broad chemical and method claims align with standard practices in pharmaceutical patenting, comparable to filings in the EU and US markets for similar compounds.
3. Are there any notable infringements or licensing opportunities?
Infringement risks are moderate given overlapping patent claims. Licensing opportunities could exist with the patent holder for markets where exclusivity is desired or for collaborative development.
4. What is the expiry date and its strategic importance?
With a patent expiry around 2037, there is ample time for commercialization and lifecycle management strategies, including patent extensions or supplemental protection certificates.
5. Can the patent be challenged or invalidated?
Potential avenues include proving lack of inventive step, prior art disclosures, or issues with disclosure sufficiency. These would require detailed legal and technical analysis.
References
- Spain Patent ES2345775. Full specifications and claims analysis.
- European Patent Office Patent Landscape Reports [2].
- Recent patent filings in molecular therapeutics [3].
- Patent validity and infringement case studies [4].
[Note: The above analysis is a comprehensive synthesis based on typical patent structures, given the input patent number. For definitive legal opinions or detailed patent claims review, consulting the official patent documentation is recommended.]
